Four Lancet factors cluster around environmental exposures and behaviors — smoking, excessive alcohol, air pollution, and (added in 2024) untreated vision loss. They are partly individual behaviors and partly structural environments. Together, they account for roughly 7–9% of preventable dementia, and they introduce considerations that the previous two clusters did not — partly because they involve choices the clinician can name but not control, and partly because they raise structural and policy questions beyond the individual encounter.
Smoking accounts for approximately 5% preventable fraction in the Lancet framework — among the largest single contributors. The mechanism includes cerebrovascular damage, accelerated oxidative stress, systemic inflammation, and the direct neurotoxic effects of tobacco constituents. Smoking cessation in midlife substantially reduces later dementia risk, and the protective effect emerges within years of quitting. The clinical implication is that the cardiovascular-and-cancer-focused smoking cessation conversation should also include cognitive endpoints — patients who do not respond to “you will have a heart attack” sometimes respond to “you will lose your mind.”
Excessive alcohol accounts for approximately 1% preventable fraction. The dose-response relationship is complicated, with older literature suggesting a J-shaped curve and more recent analyses suggesting the apparent low-dose benefit may be artifact. The current weight of evidence is that less alcohol is better for the brain, that the threshold for harm is lower than previously thought, and that the protective effects at low doses are likely overstated. The Lancet defines the threshold as more than 21 units per week, but recent recommendations have pushed the cognitive-protection target lower. The clinical conversation should reflect the updated evidence without becoming dogmatic in either direction.
Air pollution accounts for approximately 3% preventable fraction. PM2.5 particulate matter, in particular, crosses the blood-brain barrier, contributes to neuroinflammation, and correlates with elevated dementia incidence in epidemiological work. The clinical limitation is that the patient cannot control ambient air quality through individual behavior — this is a structural intervention more than a clinical one. The clinician’s role is to acknowledge the factor, support advocacy for air quality where possible, and recommend air filtration in the home for patients in high-exposure environments.
Vision loss was added in the 2024 update, with an estimated preventable fraction of approximately 2%. The mechanism parallels hearing loss — sensory deprivation, cognitive load on degraded input, withdrawal from cognitively enriching activities. The clinical intervention is straightforward: ensure cataract surgery when indicated, optimize correction of refractive error, evaluate for macular degeneration and glaucoma, and recognize that uncorrected vision problems are not merely an inconvenience but a cognitive risk factor. Cataract surgery in particular has been associated with reduced dementia incidence in observational work.
Sleep apnea is the most prominent factor not yet included in the Lancet framework. It is highly prevalent, substantially underdiagnosed, mechanistically plausible (intermittent hypoxia, glymphatic disruption, sleep fragmentation), and responsive to treatment. The exclusion from the canonical list is partly methodological — the overlap with obesity, hypertension, and cardiovascular disease makes its independent attributable risk hard to extract from epidemiological data. But clinically, sleep apnea evaluation should be in every longevity-psychiatry workup. The likely future is that sleep apnea will appear in subsequent Lancet updates.
Chronic systemic inflammation — measured by CRP, IL-6, TNF-alpha, and related markers — is similarly not on the canonical list but is increasingly recognized as a contributor. The clinical question is whether inflammation should be treated when found elevated and otherwise asymptomatic. The current evidence base supports lifestyle interventions (exercise, sleep, dietary anti-inflammatory patterns, stress reduction) more than pharmacological interventions for asymptomatic inflammatory elevation. The factor is on the workup; the pharmacological intervention is on the longer-term horizon.
The fourteen canonical factors plus the major non-canonical contributors (sleep apnea, inflammation, hormonal transitions) constitute the comprehensive longevity-psychiatry workup. Every patient in the acceleration window deserves a systematic walk-through. Every factor identified is an intervention opportunity. The aggregate effect, applied consistently across years and across patients, is what the field is for.